Dr Chris Burns, the CEO of NOVONIX Limited (ASX:NVX), shares details on a significant supply agreement with Stellantis for synthetic graphite, a milestone for the North American battery market.
Copyright 2024 – Finance News Network
Source: Finance News Network
26 Feb 2021 - Anteris Technologies Limited (ASX:AVR) CEO & Managing Director Wayne Paterson talks about the benefits of the company's Anteris DurAVR aortic replacement valve to work better and for longer, company strategy and goals for 2021.
Read More12 Oct 2022 - icetana (ASX:ICE) CEO and Managing Director Matt Macfarlane discusses revenue growth, the company's strategic placement to Macnica, changes to the share registry and the outlook ahead.
Read More24 Jun 2020 - Immutep (ASX:IMM) CEO, Marc Voigt provides an update on its clinical trials including metastatic breast cancer (MBC), its global leadership under Chief Scientist and Medical Officer, Professor Frederic Triebel, and the growing interest by big pharma in immuno-therapies.
Read More30 Jul 2021 - Novatti Group Limited (ASX:NOV) CEO, Peter Cook, provides an update on activities from the company's June quarter, discussing growth in platforms and infrastructure and the recent capital raise.
Read More20 Mar 2023 - Beston Global Food Company Limited (ASX:BFC) CEO Fabrizio Jorge discusses half-year results, the impact of weather on milk supply, lactoferrin pricing, export markets, the recent capital raising, and M&A opportunities.
Read More07 Jul 2021 - Knosys Limited (ASX:KNO Managing Director John Thompson provides an overview of the recent acquisition of LIBERO, a leading library management software business.
Read More24 May 2021 - QEM Limited (ASX:QEM) Managing Director Gavin Loyden provides an update on the company's flagship 100%-owned Julia Creek vanadium and oil shale project in North Queensland.
Read More12 Apr 2023 - eCargo Holdings Limited (ASX:ECG) Group CEO Lawrence Lun discusses recent results, strategy, opportunities post lockdown and milestones ahead.
Read More12 Oct 2022 - Immutep Limited (ASX:IMM) CEO and Executive Director Marc Voigt discusses the FDA fast track designation received in first-line non-small cell lung cancer, the company's new Phase 2 trial in soft tissue sarcoma and the outlook ahead.
Read More08 Dec 2023 - Stealth Global Holdings reports record FY23 results, driven by efficient consolidation, organic growth, and prudent financial management. CEO Mike Arnold reveals plans for further expansion, M&A, and a commitment to dividends in FY24.
Read More
